Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Ngm Biopharmaceuticals Inc.
Sponsor

Ngm Biopharmaceuticals Inc.

United States 611 Gateway Boulevard Suite 540, 94080-7017, United States

About the sponsor

Clinical research in this area focuses on colorectal cancer complicated by cancer cachexia, with attention to changes in body weight, nutritional status, and disease-related wasting.

  • Body weight maintenance
  • Cachexia management
  • Supportive oncology

The therapeutic interest in this disease setting centers on improving the clinical burden associated with cancer-related metabolic decline.

About Specializations

Ngm Biopharmaceuticals Inc. runs clinical trials in conditions such as Colorectal cancer, Cachexia, Neoplasm, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Colorectal cancer+1

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST GDNF FAMILY RECEPTOR ALPHA-LIKE
  • Sponsor:Ngm Biopharmaceuticals Inc.

Neoplasm

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ngm707
  • Sponsor:Ngm Biopharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.